First Time Loading...

Pacific Biosciences of California Inc
NASDAQ:PACB

Watchlist Manager
Pacific Biosciences of California Inc Logo
Pacific Biosciences of California Inc
NASDAQ:PACB
Watchlist
Price: 1.83 USD 3.98% Market Closed
Updated: May 5, 2024

Pacific Biosciences of California Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pacific Biosciences of California Inc
Revenue Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Pacific Biosciences of California Inc
NASDAQ:PACB
Revenue
$200.5m
CAGR 3-Years
36%
CAGR 5-Years
21%
CAGR 10-Years
22%
Thermo Fisher Scientific Inc
NYSE:TMO
Revenue
$42.9B
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
13%
Danaher Corp
NYSE:DHR
Revenue
$43.7B
CAGR 3-Years
21%
CAGR 5-Years
21%
CAGR 10-Years
9%
Mettler-Toledo International Inc
NYSE:MTD
Revenue
$3.8B
CAGR 3-Years
7%
CAGR 5-Years
5%
CAGR 10-Years
5%
Agilent Technologies Inc
NYSE:A
Revenue
$6.7B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
8%
IQVIA Holdings Inc
NYSE:IQV
Revenue
$15B
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
11%

See Also

What is Pacific Biosciences of California Inc's Revenue?
Revenue
200.5m USD

Based on the financial report for Dec 31, 2023, Pacific Biosciences of California Inc's Revenue amounts to 200.5m USD.

What is Pacific Biosciences of California Inc's Revenue growth rate?
Revenue CAGR 10Y
22%

Over the last year, the Revenue growth was 56%. The average annual Revenue growth rates for Pacific Biosciences of California Inc have been 36% over the past three years , 21% over the past five years , and 22% over the past ten years .